Recent Finacing
Recent Raise
Predemtec GmbH develops an immunoassay blood test for Alzheimer’s disease detecting six patented, prevalidated biomarkers and is conducting clinical trials to validate diagnosis and early detection in MCI patients.
Focus Areas
Recent Investors
Funding round
Investor